March 17, 2025
SOHO Insider News Multiple Myeloma

Multiple Myeloma News

Chimeric antigen therapy
Cellular Therapy Multiple Myeloma

Patient case highlights secondary tumor after CAR-T treatment for myeloma

patient data
Multiple Myeloma

Combination monoclonal antibody treatment induces responses but also infections in MM

Multiple Myeloma

A modified quadruplet therapy is feasible for older, transplant-ineligible MM patients

Multiple Myeloma

FDA grants Orphan Drug Designation for small-molecule MM therapy

Multiple Myeloma

Real-world study observes ‘superior’ outcomes with cilta-cel versus ide-cel for myeloma

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

Green light
Multiple Myeloma

FDA accepts Blenrep combo for review in relapsed or refractory MM

patient data
Multiple Myeloma

Real-world study finds this triplet therapy is an option for daratumumab-refractory myeloma

Chronic Lymphocytic Leukemia Indolent B-Cell Lymphomas Lymphoma Multiple Myeloma

Is a stronger flu vaccine better for blood cancer patients?

Multiple Myeloma News

CARTITUDE-4 findings show improved health-related quality of life with cilta-cel for multiple myeloma

Verified by MonsterInsights